Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™
ABIM Diplomates - maximum of 0.25 ABIM MOC points
Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)
Pharmacists - 0.25 Knowledge-based ACPE (0.025 CEUs)
Physician Assistant - 0.25 AAPA hour(s) of Category I credit
IPCE: 0.25 Interprofessional Continuing Education (IPCE) credit
This activity is intended for infectious disease clinicians, internists, family medicine/primary care clinicians, nurses/nurse practitioners, pharmacists, physician assistants and other members of the health care team involved in protection from COVID-19.
The goal of this activity is for the healthcare team to be better able to describe whether medical masks are noninferior to N95 respirators to prevent COVID-19 in health care workers providing routine care, based on a multicenter, randomized, noninferiority trial at 29 health care facilities in Canada, Israel, Pakistan, and Egypt from May 4, 2020, to March 29, 2022.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.
Medscape designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number: JA0007105-0000-23-017-H01-P).
Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 01/20/2024. PAs should only claim credit commensurate with the extent of their participation.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 1/20/2023
Valid for credit through: 1/20/2024
processing....
Note: The information on the coronavirus outbreak is continually evolving. The content within this activity serves as a historical reference to the information that was available at the time of this publication. We continue to add to the collection of activities on this subject as new information becomes available. It is the policy of Medscape Education to avoid the mention of brand names or specific manufacturers in accredited educational activities. However, manufacturer names related to the approved COVID-19 vaccines are provided in this activity in an effort to promote clarity. The use of manufacturer names should not be viewed as an endorsement by Medscape of any specific product or manufacturer.
It is uncertain whether medical masks offer similar protection against COVID-19 compared with N95 respirators. Systematic reviews of randomized trials and observational studies of other respiratory viruses suggest similar protection.
However, medical masks may offer less protection because of their looser fit and less effective filtration compared with N95 respirators. During the pandemic, supplies of N95 respirators were insufficient globally, and currently the high costs reduce access in low- and middle-income countries.
Regular medical masks might provide protection similar to that of N95 respirators in preventing SARS-CoV-2 infection among healthcare workers, according to the first randomized trial that tested the 2 types of masks head to head in the COVID-19 era.
Owing to limitations in the study, however, the authors were only formally able to conclude that healthcare workers who wore medical masks while treating patients with COVID-19 were not twice as likely to contract the virus as workers wearing N95 respirators.
“Nonetheless, this trial provides the best evidence to date on comparative effectiveness of mask types in preventing SARS-CoV-2 infection in health care workers providing routine patient care,” writes Roger Chou, MD, in an editorial published with the study.[1]
In summarizing, Dr Chou said that “the results indicate that medical masks may be similar to N95 respirators in Omicron-era settings with high COVID-19” rates, but the researchers set a low bar for establishing whether one is more effective than the other.
“Therefore, the results are not definitive,” Dr Chou writes.
In the study, published Tuesday in the Annals of Internal Medicine, the authors evaluated 1009 healthcare workers in Canada, Israel, Pakistan, and Egypt who had not been vaccinated against SARS-CoV-2 and had not previously been infected by the virus.[2] Participants were randomly assigned to wear either a medical mask or an N95 respirator for 10 consecutive weeks. The study period was from May 2020 to March 2022.
Reverse transcriptase polymerase chain reaction (RT-PCR) tests confirmed that COVID occurred in 52 (10.46%) of 497 participants in the medical mask group vs 47 (9.27%) of 507 in the N95 respirator group (hazard ratio [HR], 1.14; 95% CI, 0.77-1.69).
The World Health Organization recommends medical masks (sometimes called surgical masks) for routine care, whereas the Centers for Disease Control and Prevention recommends that N95s be used while caring for patients with COVID-19. Before the pandemic, research showed that N95s and medical masks carried similar risks while caring for patients with influenza-like illnesses.
Dr Chou said that decision-makers should keep in mind the uncertainty of whether one mask type is more effective than the other and should take worker preferences, N95 respirator availability, and resource constraints into consideration.
Ann Intern Med. Published online November 29, 2022.